IMF lifts global growth forecast to 3.2% in '24    Egyptian president meets Russian intelligence chief to discuss regional stability    US House passes Iran-China crude sanctions    German wholesale prices dip 3.0% in March '24    EU pledges €3.5b for oceans, environment    Asian markets drop on global jitters    Prices of electrical appliances drop by 30%    Tourism Minister mandates green certification for Red Sea hospitality, diving establishments    Strategic reductions: Balancing CO2 cuts with economic stability    Enppi, Petrojet spearhead solar power initiative at Assiut Oil Refinery with EGP 550m investment    Egypt gears up for launch of massive '500500' oncology hospital    Sydney in turmoil after stabbing of prominent bishop    Russia eyes lunar nuclear energy facility in joint Moon base with China    Prime Minister oversees 'Decent Life' healthcare initiatives, Universal Health Insurance progress    Egypt forms supreme committee to revive historic Ahl Al-Bayt Trail    US awards Samsung $6.4b chips grant for Texas project    Debt swaps could unlock $100b for climate action    US Steel shareholders approve Nippon Steel buyout    Acts of goodness: Transforming companies, people, communities    Eid in Egypt: A Journey through Time and Tradition    President Al-Sisi embarks on new term with pledge for prosperity, democratic evolution    Amal Al Ghad Magazine congratulates President Sisi on new office term    Tourism Minister inspects Grand Egyptian Museum, Giza Pyramids    Egypt's healthcare sector burgeoning with opportunities for investors – minister    Egypt starts construction of groundwater drinking water stations in South Sudan    Russians in Egypt vote in Presidential Election    Egyptian, Japanese Judo communities celebrate new coach at Tokyo's Embassy in Cairo    Uppingham Cairo and Rafa Nadal Academy Unite to Elevate Sports Education in Egypt with the Introduction of the "Rafa Nadal Tennis Program"    Egypt's powerhouse 'The Tank' Hamed Khallaf secures back-to-back gold at World Cup Weightlifting Championship"    Financial literacy becomes extremely important – EGX official    Euro area annual inflation up to 2.9% – Eurostat    Egypt builds 8 groundwater stations in S. Sudan    BYD، Brazil's Sigma Lithium JV likely    WFP delivers 1st Jordan aid convoy through Israeli crossing    UNESCO celebrates World Arabic Language Day    Motaz Azaiza mural in Manchester tribute to Palestinian journalists    Russia says it's in sync with US, China, Pakistan on Taliban    It's a bit frustrating to draw at home: Real Madrid keeper after Villarreal game    Shoukry reviews with Guterres Egypt's efforts to achieve SDGs, promote human rights    Sudan says countries must cooperate on vaccines    Johnson & Johnson: Second shot boosts antibodies and protection against COVID-19    Egypt to tax bloggers, YouTubers    Egypt's FM asserts importance of stability in Libya, holding elections as scheduled    We mustn't lose touch: Muller after Bayern win in Bundesliga    Egypt records 36 new deaths from Covid-19, highest since mid June    Egypt sells $3 bln US-dollar dominated eurobonds    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



Taking the pill!
Published in The Egyptian Gazette on 16 - 05 - 2011

CAIRO - Egypt's Supreme Administrative Court has ratified a ministerial decree of former Minister of Health Hatem el-Gabaly, pegging the prices of local pharmaceutical products to world markets.
While officials say the ruling would slash prices by up to 40 per cent, producers and experts doubt its feasibility.
Egypt consumed medicines worth LE18 billion ($3 billion) in 2010, according to the Ministry of Health. Around 40 per cent of the country's population lives on less than $2 a day, according to the World Bank. Therefore, a fair pricing scheme is "of great importance", experts say.
"Pharmaceutical products are cheap in Egypt compared to other countries. But prices here are high compared to average incomes. People with chronic ailments like hypertension, cardiac problems or diabetes cannot afford them, particularly since most of them are pensioners," Manal Labib, a 28-year-old pharmacist, told the Egyptian Mail in an interview.
Pharmaceutical sales in Egypt jumped by 15 per cent last year, and the sector may grow at the same pace in 2011, according to official reports.
Ashraf Bayoumi, the head of the Pharmaceutical Sector at the Ministry of Health, said last week that the ruling would reduce prices by 40 per cent, which is a boon for consumers.
"I have serious doubts. The former minister [el-Gabaly] wanted to wash the Ministry's hands of pricing medicines and leave it to the market," Labib argued.
"Under the present pricing system, the Health Ministry sets product prices, giving producers a fair profit margin. It is fair enough for producers and consumers and no one has complained," Labib said.
"As a pharmacist, I don't have a problem with the ruling. But producers have a problem with costs and revenues. They also have a problem because most of the active ingredients get imported. The ruling, I think, is not feasible. Some companies may stop producing certain medicines," she explained.
This North African country of 80 million people imports 80 per cent of the materials used in medicines, according to the Ministry of Health. Although investments in the pharmaceutical sector hit LE20 billion in Egypt, the country's exports stand at the trivial figure of around LE300 million annually.
"Before and after the January 25 revolution, people suffered from price hikes, including medicines," Labib added.
Pharmacies nationwide sold medicines worth LE15 billion in 2010, while LE3 billion of pharmaceutical products were consumed in State-owned and private hospitals, according to official data.
Egypt imports 12 per cent of its pharmaceutical needs annually, according to the Ministry of Health. The country's major imports include cancer drugs, infant formula, insulin and albumin. Globally, the pharmaceutical market is expected to add 5–7 per cent by the end of the year to hit $880 billion, according to IMS Health, a US-based pharmaceutical intelligence agency.
IMS forecasts Germany, France, Italy, Spain and the UK, which are Europe's top markets, to collectively grow by one to three per cent this year.
The US is expected to remain the world's largest pharmaceutical market and expand by three to five per cent this year.
Pharmaceutical sales in the US will reach $320–$330 billion, up from $310 billion in 2010, according to IMS.
"It's a strategic industry that affects people's health. But local producers must make a profit to continue and develop their products. If they make no profit, why produce then?" wondered Karam Mehanna, Deputy Chairman of the Pharmaceutical Chamber of the Federation of Egyptian Industries.
"The Higher Council of Medicine, which comprises representatives of producers and State-run supervisory agencies, should do the pricing. The ruling may cause problems rather than solve them," Mehanna said.


Clic here to read the story from its source.